| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |